Eva Corey - Concepedia

Author

Eva Corey

Also Known As

Chawnshang Chang, Corey Eva, Corey, Eva, E Corey, E. Corey, EVA COREY, Eva B. Corey, Eva Corey, Gerhard Coetzee, Peter Carroll

924

Publications

14.9K

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center VA Puget Sound Health Care System Dana-Farber Cancer Institute University of British Columbia

About

Eva Corey is an author at University of Washington specializing in medicine, urology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	49	3.7K
2	Health Sciences	4	4	518
3	Engineering	3	3	138
4	Natural Sciences	2	2	100
5	Biomolecular Engineering	1	1	22

Eva Corey

168

Publications

13.2K

Citations

H-Index

Page 1

	Year	Citations
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas, Cancer Cell UrologyHormonal ReceptorFibroblast Growth FactorFgf SignalingProstatic Disease	2017	733
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1 Heiko Johnen, Shu Lin, Támara Kuffner, Nature Medicine ObesityTumor BiologyWeight LossTumor-induced AnorexiaMedicine	2007	589
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis Jared M. Lucas, Cynthia Heinlein, Tom Kim, Cancer Discovery	2014	486
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, Journal of Clinical Investigation Scnpc Pdx ModelsUrologyStratifies Diverse PhenotypesGenitourinary CancerTumor Heterogeneity	2019	439
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics Holly M. Nguyen, Robert L. Vessella, Colm Morrissey, The Prostate	2017	307
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress Michael D. Nyquist, Alexandra Corella, Ilsa M. Coleman, Cell Reports	2020	281
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer Ali Ghoochani, En‐Chi Hsu, Merve Aslan, Cancer Research	2021	281
Prostate cancer reactivates developmental epigenomic programs during metastatic progression Mark M. Pomerantz, Xintao Qiu, Yanyun Zhu, Nature Genetics Developmental BiologyEpigenomicsCancer GenomicsProstatic DiseaseMedicine	2020	271
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers Akash Kumar, Thomas A. White, Alexandra P MacKenzie, Proceedings of the National Academy of Sciences	2011	266
Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer Maria Thadani‐Mulero, Luigi Portella, Shihua Sun, Cancer Research	2014	259

Page 1